Trials / Unknown
UnknownNCT03700957
The Impact of Docosahexaenoic Acid on the Prevention of Necrotizing Enterocolitis in Preterm Neonates
A Clinical Study on the Impact of Docosahexaenoic Acid on the Prevention of Necrotizing Enterocolitis in Preterm Neonates
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 1 Day – 3 Weeks
- Healthy volunteers
- Not accepted
Summary
The study will assess the efficacy of Docosahexaenoic Acid in reducing the incidence of necrotizing enterocolitis in premature infants.
Detailed description
The efficacy of Docosahexaenoic Acid in reducing the incidence of necrotizing enterocolitis in preterm neonates will be evalutaed through measuring its immune-modulatory effect on proinflammatory cytokines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Docosahexaenoic Acid | 100 milligrams of Docosahexaenoic Acid |
| OTHER | placebo | placebo |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-06-01
- Completion
- 2019-09-01
- First posted
- 2018-10-09
- Last updated
- 2018-10-09
Source: ClinicalTrials.gov record NCT03700957. Inclusion in this directory is not an endorsement.